We sought to describe their association with euglycemic diabetic ketoacidosis ... in the setting of type 1 diabetes. Here we describe 13 cases of SGLT-2 inhibitor–associated euDKA or ketosis ...

Key points A 28-year-old man with cocaine and alcohol use disorders presented to the emergency department with a 2-month history of worsening shortness of breath, orthopnea, and fatigue. His medical ...

Israel: A real-world analysis has provided new insights into the kidney-protective effects of sodium-glucose cotransporter-2 ...

Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Sodium-glucose cotransporter 2 inhibitor use is an independent risk factor for falls in people with type 2 diabetes.

The role of the kidney in blood glucose-level regulation was until recently underestimated. Renal gluconeogenesis, renal glucose uptake and tubular glucose reabsorption are the three ways of renal ...

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses several advantages to using an SGLT2 inhibitor in cats compared to ...

A new study has found that a group of diabetes drugs called SGLT2 inhibitors may increase the risk of a rare but dangerous ...

The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.

Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including SGLT2is and GLP-1 RAs.

and colleagues examined the association of SGLT2 inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists with falls in patients with type 2 diabetes. The analysis included annual fall ...